Singapur - inglés - HSA (Health Sciences Authority)

alcare pharmaceuticals pte ltd - cardiovascular - the steerable transseptal needle and its accessory piercing stylet are used in conjunction with a transseptal introducer to puncture the interatrial septum during a transseptal catheterization procedure to gain left heart access.

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

viatris limited - tiotropium - inhalation powder, hard capsule - tiotropium bromide

Estados Unidos - inglés - NLM (National Library of Medicine)

natureplex, llc - lanolin (unii: 7ev65eaw6h) (lanolin - unii:7ev65eaw6h), petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u) - lanolin 155 mg in 1 g - pain reliever for temporary relief of pain associated with minor skin irritations due to tattooing, piercing, and hair removal temporarily protects and helps relieve minor skin irritation due to tattooing, piercing, and hair removal

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - tiotropium bromide - inhalation solution - 2.5microgram/1dose

Singapur - inglés - HSA (Health Sciences Authority)

organon singapore pte. ltd. - follitropin beta - injection - 100 iu/0.5 ml - follitropin beta 100 iu/0.5 ml

Singapur - inglés - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - follitropin beta - injection - 50 iu/0.5 ml - follitropin beta 50 iu/0.5 ml

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

teva b.v. - tiotropium bromide - inhalation powder, hard capsule - 10 microgram(s) - anticholinergics; tiotropium bromide

Estados Unidos - inglés - NLM (National Library of Medicine)

alcon laboratories, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), sodium phosphate, dibasic, unspecified form (unii: gr686lba74) (sodium cation - unii:lyr4m0nh37), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37) - sodium chloride 7.44 mg in 1 ml - indications and usage:  bss plus is indicated for use as an intraocular irrigating solution during intraocular surgical procedures involving perfusion of the eye. contraindications:  there are no specific contraindications to the use of bss plus; however, contraindications for the surgical procedure during which bss plus is to be used should be strictly adhered to. geriatric use:  no overall differences in safety or effectiveness have been observed between elderly and younger patients. reconstitution instructions directions: use aseptic technique - remove the blue flip-off seal from the bss plus® part i (480 ml) bottle. remove the blue flip-off seal from the bss plus part ii (20 ml) vial. prepare the stoppers on both parts by using sterile alcohol wipes. - peel open a bss plus vacuum transfer device package (supplied) and remove the sterile transfer spike. note: this device is vented permitting air to enter vial during solution transfer, thereby preventing the creation of a vacuum inside the vial. an air-inlet filter is provided to protect the system. do not remove the air-inlet filter. - remove protector from the white plastic piercing pin. - firmly grasp device from behind the flange and insert the white plastic piercing pin into the upright rubber stopper of the bss plus part ii (20 ml) vial. - remove guard from filter needle. firmly grasp vial in the palm of one hand and with thumb and index finger, hold plastic flange against top of vial. - invert vial and immediately insert filter needle into the outer target of the rubber stopper of the bss plus part i (480 ml) bottle. (see illustration.) - fluid will automatically transfer from the vial into the large vacuum bottle unless filter becomes occluded or loss of vacuum occurs. note: an excess amount of bss plus part ii is provided in each vial. a non-transferred solution residual of approximately 0.3 ml can be expected to remain in the vial. - immediately remove needle from the bss plus part i container and discard it after solution transfer has been completed. - place a sterile safety cap over the rubber stopper of part i if the solution is not going to be used immediately. mix the solution gently until uniform. peel off the right-hand side of part i bottle label (fully reconstituted bss plus solution). record the patient’s name and the date and time of reconstitution. bss plus solution is now ready for use. caution: reconstituted bss plus solution must be used within six hours of mixing. discard any solution which has aged beyond that time. never use the same bottle of bss plus solution on more than one patient. alternative transfer method if preferred, the contents of the bss plus part ii component may be aspirated with an 18-gauge cannula attached to a 20 ml syringe and then transferred into the part i bottle. alcon distributed by: alcon laboratories, inc. fort worth, texas 76134 usa revised: april 2023

Estados Unidos - inglés - NLM (National Library of Medicine)

hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - dextrose monohydrate 5 g in 100 ml - intravenous solutions containing dextrose and sodium chloride are indicated for parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride as required by the clinical condition of the patient. none known. to open: tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. to add medication - prepare additive port. - using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. - the additive port may be protected by covering with an additive cap. - mix container contents thoroughly. preparation for administration (use aseptic technique) - close flow control clamp of administration set. - remove cover from outlet port at bottom of container. - insert piercing pin of administration set into port with a twisting motion until the set is firmly seated.

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - olodaterol hydrochloride; tiotropium bromide - inhalation solution - 2.5microgram/1dose ; 2.5microgram/1dose